Nutex Health
NUTX
51 hedge funds and large institutions have $12M invested in Nutex Health in 2022 Q3 according to their latest regulatory filings, with 10 funds opening new positions, 15 increasing their positions, 17 reducing their positions, and 10 closing their positions.
0% more funds holding
Funds holding: 51 → 51 (0)
0% more ownership
Funds ownership: 0.01% → 0.01% (+0%)
0% more first-time investments, than exits
New positions opened: 10 | Existing positions closed: 10
12% less repeat investments, than reductions
Existing positions increased: 15 | Existing positions reduced: 17
49% less capital invested
Capital invested by funds: $23.6M → $12M (-$11.5M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Creative Planning
Overland Park,
Kansas
|
+$2.32M |
| 2 |
Millennium Management
New York
|
+$1.42M |
| 3 |
E
Ergoteles
New York
|
+$1.15M |
| 4 |
Morgan Stanley
New York
|
+$601K |
| 5 |
State Street
Boston,
Massachusetts
|
+$400K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Goldman Sachs
New York
|
-$2.68M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$839K |
| 3 |
HF
HRT Financial
New York
|
-$477K |
| 4 |
BCV
Banque Cantonale Vaudoise
Lausanne,
Switzerland
|
-$152K |
| 5 |
Tudor Investment Corp
Stamford,
Connecticut
|
-$149K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
51
Citadel Advisors
Miami,
Florida
| – | -$839K | -1,735 | Closed |
|
|
BCV
52
Banque Cantonale Vaudoise
Lausanne,
Switzerland
| – | -$152K | -314 | Closed |
|
|
53
Tudor Investment Corp
Stamford,
Connecticut
| – | -$149K | -308 | Closed |
|
54
D.E. Shaw & Co
New York
| – | -$141K | -292 | Closed |
|
55
Verition Fund Management
Greenwich,
Connecticut
| – | -$52K | -107 | Closed |
|
|
AWM
56
Apollon Wealth Management
Mount Pleasant,
South Carolina
| – | -$49K | -102 | Closed |
|
57
Mirae Asset Global Investments
Seoul,
South Korea
| – | -$36K | -74 | Closed |
|
58
Cetera Investment Advisers
Schaumburg,
Illinois
| – | -$32K | -67 | Closed |
|
59
UBS Group
Zurich,
Switzerland
| – | -$424 | -1 | Closed |
|
NUTX Hedge Fund Activity: Q3 2022 in Review
51 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Nutex Health (NUTX) for Q3 2022, worth a combined $12M — down 49% from $23.6M a quarter earlier.
Fund positioning in NUTX was balanced in Q3 2022: 10 funds opened new positions, 10 closed out, 15 added to existing stakes and 17 trimmed.
The largest buyer was Creative Planning, opening a new position worth an estimated $2.32M. The largest seller was Goldman Sachs, cutting an estimated $2.68M.
- 51 institutional investors held Nutex Health (NUTX) as of Q3 2022, unchanged from Q2 2022.
- Funds reported $12M of Nutex Health stock for Q3 2022, down 49% quarter-over-quarter.
- 10 funds opened new Nutex Health positions in Q3 2022 and 10 closed out, a net change of 0 holders.
- The largest Nutex Health buyer in Q3 2022 was Creative Planning, an estimated $2.32M added.
- The largest Nutex Health seller in Q3 2022 was Goldman Sachs, an estimated $2.68M sold.
Based on aggregated 13F filings for Q3 2022.